EKG vs HELX: Holdings Overlap & Returns
Over the year to Nov 13, 2026, EKG returned +21.3% to HELX's +22.6%; 21% of their weight is in the same names.
- Return gap
- +1.3 pts1 year to Nov 13, 2026: HELX ahead, total return
- Fee gap
- 0.15 ptsA year: EKG 0.65%, HELX 0.50%, per filings dated Jan 28, 2026 and Jul 27, 2026
- Overlap
- 21%Share of the two books held in common, holdings dated Nov 12, 2026 and Jun 30, 2026
- Net flow
- –Needs daily flows for both funds
Compare two other funds
Growth of 100
Drawn from the numbers on this page. Growth of 100, both funds, distributions reinvested
EKG +21.3%, HELX +22.6%: HELX +1.3 pts ahead, 1 year, Nov 13, 2025 to Nov 13, 2026.
ShareUse this comparison
Cost to trade
Hypothetical. A $10,000 order in EKG costs about $13.50 one way and $27.00 in and out, at a median spread of 0.27%. The 0.27% spread is EKG’s 30-day median, from First Trust (fund page).
Fees over time
Hypothetical. $10,000 in EKG for 10 years at 0.65% a year costs about $1,068 in fees and lost growth; HELX at 0.50% would cost $827. Assumes 6% a year before fees, a sample rate, not a forecast.
How each fund moved
43% of EKG's weight is in S&P 500 companies and 58% is outside the index. Holdings as of Nov 12, 2026.
15% of HELX's weight is in S&P 500 companies and 85% is outside the index. Holdings as of Jun 30, 2026.
Key numbers
HELX costs 0.15 points a year less; their one-year returns differ by 1.3 points; HELX is 3.7 times larger.
Pair scorecard
Open the table
Points (pts) are percentage points.
| Total return, 1 year | +21.3% | +22.6% |
|---|---|---|
| Below its all-time high | 10.1%, high on Oct 29, 2026 | 26.5%, high on Sep 7, 2021 |
| What it tracks | Healthcare innovation and GLP-1 | Healthcare innovation and GLP-1 |
| Expense ratio | 0.65% | 0.50% |
| Net assets, as of Nov 12, 2026 | $9.1m | $34m |
| Holdings in common | 21% |
The numbers behind it
Net assets on Nov 12, 2026: $9.1m for First Trust Nasdaq Lux Digital Health Solutions ETF and $34m for Franklin Genomic Advancements ETF.
Holdings in common uses holdings dated Jun 30, 2026 and Nov 12, 2026.
What they share
By the books each fund has filed, EKG and HELX hold 21% of their money in the same securities at the same weight. Holdings dated Jun 30, 2026 and Nov 12, 2026.
half
21% in common
Held in common
Show all 12 holdings
| Natera, Inc. | 7.78% | 7.46% |
| Guardant Health, Inc. | 3.77% | 9.09% |
| Tempus AI, Inc. (Class A) | 3.11% | 1.95% |
| Twist Bioscience Corporation | 1.77% | 2.85% |
| Adaptive Biotechnologies Corporation | 1.53% | 3.99% |
| GRAIL, Inc. | 1.79% | 1.09% |
| CareDx, Inc. | 1.35% | 0.82% |
| IQVIA Holdings Inc. | 8.04% | 0.75% |
| Hinge Health, Inc. (Class A) | 2.68% | 0.70% |
| QIAGEN N.V. | 3.64% | 0.48% |
| Veracyte, Inc. | 0.45% | 1.64% |
| GeneDx Holdings Corp. | 0.49% | 0.14% |
Only in EKG
Show all 8 holdings
| Intuitive Surgical, Inc. | 9.05% |
| Veeva Systems Inc. (Class A) | 8.20% |
| DexCom, Inc. | 6.93% |
| ResMed Inc. | 3.85% |
| Illumina, Inc. | 3.80% |
| Align Technology, Inc. | 3.23% |
| Globus Medical, Inc. (Class A) | 3.19% |
| Insulet Corporation | 3.19% |
Only in HELX
Show all 8 holdings
| KRYSTAL BIOTECH INC | 6.33% |
| LIGAND PHARMACEUTICALS INC | 4.62% |
| UNITED THERAPEUTICS CORP | 3.51% |
| BRIDGEBIO PHARMA INC | 3.50% |
| ELI LILLY & COMPANY | 2.95% |
| VERTEX PHARMACEUTICALS INC | 2.75% |
| ASTRAZENECA PLC | 2.70% |
| TRAVERE THERAPEUTICS INC | 2.59% |
Side by side
Open the table
| Fund | First Trust Nasdaq Lux Digital Health Solutions ETF · Holds 51 stocks in healthcare innovation and GLP-1, 42% of its weight in S&P 500 companies | Franklin Genomic Advancements ETF · Holds 61 stocks in healthcare innovation and GLP-1, 15% of its weight in S&P 500 companies |
| Issuer | First Trust | Franklin |
| Theme | Healthcare innovation and GLP-1 | Healthcare innovation and GLP-1 |
| In the S&P 500 | 42.5% | 14.9% |
| Active share vs the S&P 500 | 99.6% | 97.2% |
| In the Nasdaq-100 | 16.0% | 7.5% |
| Holdings | 51 | 61 |
| Top ten, share of the fund | 58.3% | 47.1% |
| Expense ratio | 0.65% | 0.50% |
| Fee for the differing part | 0.65% | 0.51% |
| Total return, 1 year | +21.3% | +22.6% |
| vs its benchmark | not measured | not measured |
| Below its high | −10.1% | −26.5% |
| Net assets, as of Nov 12, 2026 | $9.1m | $34m |
As of Nov 13, 2026. Source: ETFIQ.
Window by window
Open the table
| 3 months | +6.7% | +5.0% |
|---|---|---|
| 6 months | +43.1% | +29.7% |
| 1 year | +21.3% | +22.6% |
| 3 years | +69.3% | +57.1% |
| Since launch (Not the same days: EKG Mar 2022 · HELX Feb 2020) | +13.3% | +78.8% |
About EKG
By weight, 42% of EKG's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 100%. The top ten holdings are 58% of the fund across 51 positions, as published by its issuer for Nov 12, 2026.
More
Over the year to Nov 13, 2026 the fund returned +21.3% with distributions reinvested. It sits 10.1% below its all-time high of Oct 29, 2026.
About HELX
By weight, 15% of HELX's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 97%. The top ten holdings are 47% of the fund across 61 positions, as filed for Jun 30, 2026.
More
Over the year to Nov 13, 2026 the fund returned +22.6% with distributions reinvested. It sits 26.5% below its all-time high of Sep 7, 2021.
21% of the two portfolios are the same securities at the same weight.
Questions people ask
Do EKG and HELX hold the same stocks?
By their latest filings, 21% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.
Other comparisons
Sources
More
Links are sources, not endorsements. A comparison is not a recommendation.
Copy and cite
Cite this pageCitation, APA and Markdown
ETFIQ, EKG against HELX, data as of Nov 13, 2026. https://etfiq.com/compare/themes/ekg-vs-helx
ETFIQ. (Nov 13, 2026). EKG against HELX. Retrieved from https://etfiq.com/compare/themes/ekg-vs-helx
[EKG against HELX (ETFIQ, Nov 13, 2026)](https://etfiq.com/compare/themes/ekg-vs-helx)
Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.